Related Experiment Video

Updated: Aug 15, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Mdm2 in growth signaling and cancer

Yaara Levav-Cohen1, Sue Haupt, Ygal Haupt

  • 1The Hebrew University Hadassah Medical School, Lautenberg Center for General and Tumor Immunology, Jerusalem, Israel.

Growth Factors (Chur, Switzerland)
|October 26, 2005
PubMed

Insights

Mdm2 plays a key role in cancer by inhibiting the tumor suppressor p53 and through p53-independent pathways. Targeting Mdm2 offers a promising strategy for developing novel anti-cancer drugs.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Mdm2 is directly linked to cancer development.
  • Elevated Mdm2 expression is common in various cancers.
  • Mdm2 primarily inhibits the tumor suppressor p53, but also has p53-independent functions.

Purpose of the Study:

  • To review the multifaceted roles of Mdm2 in cancer.
  • To highlight Mdm2's involvement in both p53-dependent and independent cellular processes.
  • To underscore Mdm2 as a potential therapeutic target in oncology.

Main Methods:

  • Review of genetic and biochemical evidence.
  • Analysis of Mdm2's interactions with key cellular proteins and pathways.
  • Examination of Mdm2's role in cell cycle regulation and signaling pathways.

Main Results:

  • Mdm2 inhibits tumor suppressor p53 activity and stability.
  • Mdm2 regulates cell cycle progression via pRb/E2F.
  • Mdm2 influences PI3K/Akt, steroid hormone receptors, and TGF-beta pathways.

Conclusions:

  • Mdm2's diverse oncogenic functions, both p53-dependent and independent, are crucial in cancer.
  • Dysregulated Mdm2 contributes to tumorigenesis through multiple signaling pathways.
  • Mdm2 represents a significant target for anti-cancer drug development.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...